ad image

Biomarkers

1 / 1
The Biomarker Revolution in Medicine and Drug Development
Biomarkers

The Biomarker Revolution in Medicine and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-16Mar 10, 2025
Firefly Neuroscience
MDD

Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study for Major Depressive Disorder

Firefly Neuroscience

PR-10-24-NI-46Oct 16, 2024
U.S. Food & Drug Administration
Alzheimer's Diagnostic Test

FDA Permits Marketing for New Test to Improve Diagnosis of Alzheimer's Disease

U.S. Food & Drug Administration

PR-M05-22-02May 04, 2022
Adding Dimensionality to Data Mapping for Higher-Level Analysis
Data Mapping

Adding Dimensionality to Data Mapping for Higher-Level Analysis

Zachary Pitluk, Ph.D.

Paradigm4

PAO-04-022-CL-03Apr 12, 2022
Araclon Biotech
Alzheimer's Vaccine

Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's

Araclon Biotech

PR-M03-22-06Mar 15, 2022
Biofidelity
Series A Funding

Biofidelity Raises $23M in Series A+ Financing Led by Octopus Ventures to Launch ASPYRE Technology

Biofidelity

PR-M02-22-04Feb 07, 2022
RNA Biomarkers for Early Lung Cancer Diagnosis
RNA Biomarkers

RNA Biomarkers for Early Lung Cancer Diagnosis

Ron Andrews

OncoCyte

PAP-Q1-20-CL-014Mar 19, 2020
Caprion Biosciences
M&A

Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development

Caprion Biosciences

PR-M08-19-NI-028Aug 09, 2019
Celsius Therapeutics
Collaboration

Celsius Therapeutics Signs Collaboration Agreement with Janssen to Identify Response Biomarkers for Ulcerative Colitis

Celsius Therapeutics

PR-M07-19-NI-026Jul 11, 2019
Roche
Companion Diagnostics

Roche to Develop Companion Diagnostic Test to Help Identify Patients Eligible for Anti-PD-1 Therapy Based on Biomarker Expression, Not Location, of Solid Tumors

Roche

PR-M12-18-NI-050Dec 14, 2018
Versant Health
Alzheimer's Disease

Ocular Technology Provides Early Detection of Alzheimer's Disease

Versant Health

PR-M12-18-NI-014Dec 05, 2018
1 / 1